Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 4, 2012
Patient-reported outcome instruments used to assess pain and functioning in studies of bisphosphonate treatment for bone metastasesLouis S Matza, Lesley J Fallowfield, Karen C Chung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2006
Quality of life in the intergroup exemestane study: a randomized trial of exemestane versus continued tamoxifen after 2 to 3 years of tamoxifen in postmenopausal women with primary breast cancerLesley J Fallowfield, Judith M Bliss, Lucy S Porter, et al.
Journal of the National Cancer Institute|August 7, 2009
International guidelines for management of metastatic breast cancer: combination vs sequential single-agent chemotherapyFatima Cardoso, Philippe L Bedard, Eric P Winer, et al.
Breast Cancer Research and Treatment|September 8, 2010
Anastrozole and letrozole: an investigation and comparison of quality of life and tolerabilityJ Michael Dixon, Lorna Renshaw, Carolyn Langridge, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 27, 2013
Pain and health-related quality of life in patients with advanced solid tumours and bone metastases: integrated results from three randomized, double-blind studies of denosumab and zoledronic acidRoger von Moos, Jean-Jacques Body, Blair Egerdie, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 7, 2004
Implementing the UK Medical Research Council (MRC) RT01 trial (ISRCTN 47772397): methods and practicalities of a randomised controlled trial of conformal radiotherapy in men with localised prostate cancerMatthew R Sydes, Richard J Stephens, A Rollo Moore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2021
Endocrine Treatment and Targeted Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: ASCO Guideline UpdateHarold J Burstein, Mark R Somerfield, Debra L Barton, et al.
The New England Journal of Medicine|March 12, 2004
A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancerR Charles Coombes, Emma Hall, Lorna J Gibson, et al.
Pageof 3